Marthe Fourcade

Carmot Therapeutics Inc. was valued at $1.25 billion in May. Half a year later, the company is selling to Swiss drugmaker Roche Holding AG for more than double that amount, fueled by the frenzied demand for obesity medicines.

Carmot Therapeutics Inc. was valued at $1.25 billion in May. Half a year later, the company is selling to Swiss drugmaker Roche Holding AG for more than double that amount, fueled by the frenzied demand for obesity medicines.

Roche Holding AG said an experimental medicine helped women with a particular breast cancer mutation live longer without the disease progressing.

Roche Holding AG said an experimental breast-cancer treatment will get an expedited review from US regulators after showing it helped patients live longer without the disease progressing.

Ipsen SA and partner Genfit SA won US regulators’ clearance for the first new treatment option in eight years for patients with a rare liver disease.

Johnson Matthey Plc shares soared by more than a third after announcing the sale of its catalyst business to Honeywell International Inc. for an enterprise value of about £1.8 billion ($2.4 billion) in cash.

A group of investors led by the owner of several boutique New York hotels agreed to take Soho House & Co. private in a $2.7 billion deal for the members’ club operator that’s struggled since its initial public offering.

Cruise Ship Outbreak Points to Hantavirus Spreading Among Humans

A 25-year-old man placed in isolation in Italy tested negative for hantavirus, easing concerns about transmission on a flight that briefly hosted an infected Dutch woman.

AstraZeneca Plc won the endorsement of an advisory panel to the European Medicines Agency for a new breast cancer medicine that didn’t similarly sway US regulators.